Intravitreal aflibercept in routine clinical practice: 24-month results from the global cohort of pretreated patients with diabetic macular edema in the AURIGA study

被引:0
|
作者
Donati, Simone [1 ]
Mura, Marco [2 ]
Giocanti-Auregan, Audrey [3 ]
Hoerauf, Hans [4 ]
Yang, Chang-Hao [5 ]
Allmeier, Helmut [6 ]
Machewitz, Tobias [7 ]
Santoro, Elina [8 ]
机构
[1] Univ Insubria, Dept Med & Surg, Varese, Italy
[2] King Khalid Eye Specialist Hosp, Riyadh, Saudi Arabia
[3] Sorbonne Paris Nord Univ, Hop Avicenne, Bobigny, France
[4] Univ Med Gottingen, Augenklin, Gottingen, Germany
[5] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan
[6] Bayer Consumer Care AG, Basel, Basel Stadt, Switzerland
[7] Bayer AG, Berlin, Germany
[8] Surgut Reg Clin Hosp, Surgut, Russia
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
2637
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Intravitreal Aflibercept for the Treatment of Diabetic Macular Edema in Routine Clinical Practice: Results from the 24-Month AURIGA Observational Study
    Donati, Simone
    Yang, Chang-Hao
    Xu, Xun
    Mura, Marco
    Giocanti-Auregan, Audrey
    Hoerauf, Hans
    Allmeier, Helmut
    Machewitz, Tobias
    Johnson, Kristian T.
    Santoro, Elina
    [J]. OPHTHALMOLOGY AND THERAPY, 2024, 13 (01) : 161 - 178
  • [2] Intravitreal Aflibercept for the Treatment of Diabetic Macular Edema in Routine Clinical Practice: Results from the 24-Month AURIGA Observational Study
    Simone Donati
    Chang-Hao Yang
    Xun Xu
    Marco Mura
    Audrey Giocanti-Aurégan
    Hans Hoerauf
    Helmut Allmeier
    Tobias Machewitz
    Kristian T. Johnson
    Elina Santoro
    [J]. Ophthalmology and Therapy, 2024, 13 : 161 - 178
  • [3] Aflibercept in the clinical routine: the AURIGA study. The 24-month results of the German cohort of treatment-naïve patients with diabetic macular edema receiving intravitreal aflibercept
    Ulbig, Michael
    Brinkmann, Christian Karl
    Mirshahi, Alireza
    Hoerauf, Hans
    Allmeier, Helmut
    Machewitz, Tobias
    Scholz, Paula
    Keramas, Georgios
    Khoramnia, Ramin
    [J]. OPHTHALMOLOGIE, 2024,
  • [4] Intravitreal aflibercept in routine clinical practice: 24-month results from the global treatment-naive cohort with macular edema secondary to central retinal vein occlusion in the AURIGA study
    Giocanti-Auregan, Audrey
    Yang, Chang-Hao
    Donati, Simone
    Allmeier, Helmut
    Machewitz, Tobias
    Rittenhouse, Kay D.
    Hoerauf, Hans
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [5] Evaluation of Intravitreal Aflibercept Treatment Effectiveness in UK Routine Clinical Practice for Patients with Diabetic Macular Edema: 24-month Outcomes of the DRAKO Study
    Talks, J.
    Sivaprasad, S.
    Kelly, S. P.
    Ghanchi, F.
    Kotagiri, A.
    Saddiq, M.
    Scanlon, P.
    [J]. EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2022, 32 (1_SUPPL) : 7 - 8
  • [6] Intravitreal aflibercept for diabetic macular edema in real-world clinical practice in Japan: 24-month outcomes
    Sugimoto, Masahiko
    Handa, Chiharu
    Hirano, Kazufumi
    Sunaya, Toshiyuki
    Kondo, Mineo
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 260 (11) : 3489 - 3498
  • [7] Intravitreal aflibercept for diabetic macular edema in real-world clinical practice in Japan: 24-month outcomes
    Masahiko Sugimoto
    Chiharu Handa
    Kazufumi Hirano
    Toshiyuki Sunaya
    Mineo Kondo
    [J]. Graefe's Archive for Clinical and Experimental Ophthalmology, 2022, 260 : 3489 - 3498
  • [8] Real-World Management of Macular Edema Secondary to Retinal Vein Occlusion with Intravitreal Aflibercept: 24-month Results from the AURIGA Observational Study
    Audrey Giocanti-Aurégan
    Simone Donati
    Hans Hoerauf
    Helmut Allmeier
    Kay D. Rittenhouse
    Tobias Machewitz
    Chang-Hao Yang
    [J]. Ophthalmology and Therapy, 2024, 13 : 179 - 203
  • [9] Real-World Management of Macular Edema Secondary to Retinal Vein Occlusion with Intravitreal Aflibercept: 24-month Results from the AURIGA Observational Study
    Giocanti-Auregan, Audrey
    Donati, Simone
    Hoerauf, Hans
    Allmeier, Helmut
    Rittenhouse, Kay D.
    Machewitz, Tobias
    Yang, Chang-Hao
    [J]. OPHTHALMOLOGY AND THERAPY, 2024, 13 (01) : 179 - 203
  • [10] Aflibercept in a real-world setting: the AURIGA study 24-month results of the German cohort of treatment-naive patients with macular edema following retinal vein occlusion receiving intravitreal aflibercept
    Wachtlin, Joachim
    Kaymak, Hakan
    Hoerauf, Hans
    Allmeier, Helmut
    Machewitz, Tobias
    Scholz, Paula
    Schuerks, Markus
    Feltgen, Nicolas
    [J]. OPHTHALMOLOGIE, 2024, 121 (08): : 650 - 657